With the increase of diabetes prevalence in Asia and the rise of Asia’s middle classes, the demand for newer and better treatments will provide opportunities for Western medtech companies.
The finger-prick alternative may help diabetic patients more effectively monitor their condition.
A lack of quality, locally made products opens the door for Western device companies.
The cognitive app that aims to make daily diabetes management easier and more informative is in the final development stage.
The coin-sized device could aid in the early diagnosis of retinal diseases.
Via partnerships with pharmaceutical companies, Insulet expands its platform technology past insulin delivery.
Announced at CES 2016, the cognitive app will leverage predictive analytics to help patients better manage their condition.
Meaningful data integration and patient empowerment are driving next-generation diabetes technology.
This month MedTech Intelligence will cover the diabetes market, along with technologies and solutions that are improving patient quality of life.
As the incidence of diabetes across Asia expands, demand for medical devices and drugs to treat the disease is intensifying.